Kali S Thomas1,2, Jessica A Ogarek2, Joan M Teno3, Pedro L Gozalo1,2, Vincent Mor1,2. 1. Center of Innovation in Long-Term Services and Supports, U.S. Department of Veterans Affairs Medical Center, Providence, Rhode Island. 2. Center for Gerontology and Healthcare Research, Brown University School of Public Health, Providence, Rhode Island. 3. Division of General Internal Medicine and Geriatrics, Oregon Health Science University, Portland, Oregon.
Abstract
Background: To develop a score to predict mortality using the Minimum Data Set 3.0 (MDS 3.0) that can be readily calculated from items collected during nursing home (NH) residents' admission assessments. Participants: We developed a training cohort of Medicare beneficiaries newly admitted to United States NHs during 2012 (N = 1,426,815) and a testing cohort from 2013 (N = 1,160,964). Methods: Data came from the MDS 3.0 assessments linked to the Medicare Beneficiary Summary File. Using the training dataset, we developed a composite MDS 3.0 Mortality Risk Score (MRS3) consisting of 17 clinical items and patients' age groups based on their relation to 30-day mortality. We assessed the calibration and discrimination of the MRS3 in predicting 30- and 60-day mortality and compared its performance to the Charlson Comorbidity Index and the clinician's assessment of 6-month prognosis measured at admission. Results: The 30- and 60-day mortality rates for the testing population were 2.8% and 5.6%, respectively. Results from logistic regression models suggest that the MRS3 performed well in predicting death within 30 and 60 days (C-Statistics of 0.744 [95% confidence limit (CL) = 0.741, 0.747] and 0.709 [95% CL = 0.706, 0.711], respectively). The MRS3 was a superior predictor of mortality compared to the Charlson Comorbidity Index (C-statistics of 0.611 [95% CL = 0.607, 0.615] and 0.608 [95% CL = 0.605, 0.610]) and the clinicians' assessments of patients' 6-month prognoses (C-statistics of 0.543 [95% CL = 0.542, 0.545] and 0.528 [95% CL = 0.527, 0.529]). Conclusions: The MRS3 is a good predictor of mortality and can be useful in guiding decision-making, informing plans of care, and adjusting for patients' risk of mortality.
Background: To develop a score to predict mortality using the Minimum Data Set 3.0 (MDS 3.0) that can be readily calculated from items collected during nursing home (NH) residents' admission assessments. Participants: We developed a training cohort of Medicare beneficiaries newly admitted to United States NHs during 2012 (N = 1,426,815) and a testing cohort from 2013 (N = 1,160,964). Methods: Data came from the MDS 3.0 assessments linked to the Medicare Beneficiary Summary File. Using the training dataset, we developed a composite MDS 3.0 Mortality Risk Score (MRS3) consisting of 17 clinical items and patients' age groups based on their relation to 30-day mortality. We assessed the calibration and discrimination of the MRS3 in predicting 30- and 60-day mortality and compared its performance to the Charlson Comorbidity Index and the clinician's assessment of 6-month prognosis measured at admission. Results: The 30- and 60-day mortality rates for the testing population were 2.8% and 5.6%, respectively. Results from logistic regression models suggest that the MRS3 performed well in predicting death within 30 and 60 days (C-Statistics of 0.744 [95% confidence limit (CL) = 0.741, 0.747] and 0.709 [95% CL = 0.706, 0.711], respectively). The MRS3 was a superior predictor of mortality compared to the Charlson Comorbidity Index (C-statistics of 0.611 [95% CL = 0.607, 0.615] and 0.608 [95% CL = 0.605, 0.610]) and the clinicians' assessments of patients' 6-month prognoses (C-statistics of 0.543 [95% CL = 0.542, 0.545] and 0.528 [95% CL = 0.527, 0.529]). Conclusions: The MRS3 is a good predictor of mortality and can be useful in guiding decision-making, informing plans of care, and adjusting for patients' risk of mortality.
Authors: Debra Saliba; Malia Jones; Joel Streim; Joseph Ouslander; Dan Berlowitz; Joan Buchanan Journal: J Am Med Dir Assoc Date: 2012-07-10 Impact factor: 4.669
Authors: Pieter T M van Dijk; David R Mehr; Marcel E Ooms; Richard Madsen; Greg Petroski; Dinnus H Frijters; Anne Margriet Pot; Miel W Ribbe Journal: J Am Geriatr Soc Date: 2005-04 Impact factor: 5.562
Authors: Jeffrey A Kline; Pierre-Marie Roy; Martin P Than; Jackeline Hernandez; D Mark Courtney; Alan E Jones; Andrea Penaloza; Charles V Pollack Journal: Thromb Res Date: 2012-04-03 Impact factor: 3.944
Authors: Keith A A Fox; Omar H Dabbous; Robert J Goldberg; Karen S Pieper; Kim A Eagle; Frans Van de Werf; Alvaro Avezum; Shaun G Goodman; Marcus D Flather; Frederick A Anderson; Christopher B Granger Journal: BMJ Date: 2006-10-10
Authors: Paul Q Reynolds; Neal W Sanders; Jonathan S Schildcrout; Nathaniel D Mercaldo; Paul J St Jacques Journal: Anesthesiology Date: 2011-06 Impact factor: 7.892
Authors: Cassandra L Hua; Kali S Thomas; Jennifer N Bunker; Pedro L Gozalo; Emmanuelle Bélanger; Susan L Mitchell; Joan M Teno Journal: J Am Geriatr Soc Date: 2021-11-19 Impact factor: 5.562
Authors: Lacey Loomer; Jessica A Ogarek; Susan L Mitchell; Angelo E Volandes; Roee Gutman; Pedro L Gozalo; Ellen M McCreedy; Vincent Mor Journal: J Am Geriatr Soc Date: 2020-11-07 Impact factor: 5.562
Authors: Joshua D Niznik; Song Zhang; Maria K Mor; Xinhua Zhao; Mary Ersek; Sherrie L Aspinall; Walid F Gellad; Joshua M Thorpe; Joseph T Hanlon; Loren J Schleiden; Sydney Springer; Carolyn T Thorpe Journal: J Am Geriatr Soc Date: 2018-10-18 Impact factor: 5.562
Authors: Ellen M McCreedy; Xiaofei Yang; Susan L Mitchell; Roee Gutman; Joan Teno; Lacey Loomer; Patience Moyo; Angelo Volandes; Pedro L Gozalo; Emmanuelle Belanger; Jessica Ogarek; Vincent Mor Journal: BMC Geriatr Date: 2022-04-08 Impact factor: 3.921
Authors: Susan L Mitchell; Angelo E Volandes; Roee Gutman; Pedro L Gozalo; Jessica A Ogarek; Lacey Loomer; Ellen M McCreedy; Ruoshui Zhai; Vincent Mor Journal: JAMA Intern Med Date: 2020-08-01 Impact factor: 21.873